Molecular Formula | C31H30FN5O4 |
Molar Mass | 555.6 |
Density | 1.39±0.1 g/cm3(Predicted) |
Boling Point | 782.6±60.0 °C(Predicted) |
Solubility | Soluble in DMSO |
pKa | 3.41±0.30(Predicted) |
Storage Condition | -20℃ |
Use | PF-06882961 is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist. |
Reference Show more | 1. 20th SCI/RSC Medicinal Chemistry Symposium.2. Méndez M, et al. Design, Synthesis, and Pharmacological Evaluation of Potent Positive Allosteric Modulators of the Glucagon-like Peptide-1 Receptor (GLP-1R). J Med Chem. 2019 Oct 23.3. POSSIBLE SIDE EFFECTS AND RISKS OF THE STUDY DRUG AND PROCEDURES. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.8 ml | 8.999 ml | 17.999 ml |
5 mM | 0.36 ml | 1.8 ml | 3.6 ml |
10 mM | 0.18 ml | 0.9 ml | 1.8 ml |
5 mM | 0.036 ml | 0.18 ml | 0.36 ml |